Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease
Open Access
- 3 July 2015
- journal article
- review article
- Published by Springer Science and Business Media LLC in The Esophagus
- Vol. 51 (1), 11-21
- https://doi.org/10.1007/s00535-015-1098-4
Abstract
In the past decades, continuous effort has been paid to deeply understanding the pathophysiology of inflammatory bowel diseases (IBD), such as ulcerative colitis or Crohn's disease. As the disease typically arises as chronic inflammation of the gastrointestinal mucosa, research has been focused on how such an uncontrolled, deleterious immune response may arise and persist in a certain cohort of patients. Based on those immunologic analyses, the establishment of anti-TNF-α therapy, and the following series of biologic agents achieved great success and dramatically changed the therapeutic strategy of IBD patients. However, to guarantee long-term remission of the disease, the therapeutic standard has been raised to achieve "mucosal healing", which requires complete repair of the gastrointestinal mucosa. Recent studies have revealed the unexpected importance of epithelial cells in the pathophysiology of IBD. The general barrier function as well as the cell lineage-specific functions have been deeply attributed to the development of chronic intestinal inflammation. Also, the groundbreaking establishment of the in vitro intestinal stem cell culture system has opened up a way of developing stem cell transplantation therapy to treat otherwise refractory ulcers that may persist in IBD patients. In this review, we would like to focus on the role of epithelial cells in the pathophysiology of IBD, and also give a perspective to the upcoming development of regenerative therapies that may become one of the therapeutic choices to achieve mucosal healing in refractory patients of IBD.Keywords
This publication has 121 references indexed in Scilit:
- Directed differentiation of human pluripotent stem cells into intestinal tissue in vitroNature, 2010
- Paneth cells constitute the niche for Lgr5 stem cells in intestinal cryptsNature, 2010
- Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem CellsCell, 2010
- Intestinal stem cells lacking the Math1 tumour suppressor are refractory to Notch inhibitorsNature Communications, 2010
- IKK/NF‐κB and STAT3 pathways: central signalling hubs in inflammation‐mediated tumour promotion and metastasisEMBO Reports, 2009
- A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cellsNature, 2008
- Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2EMBO Reports, 2008
- Identification of stem cells in small intestine and colon by marker gene Lgr5Nature, 2007
- Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesisNature Genetics, 2007
- Cellular and Molecular Mechanisms of the Epithelial Repair in IBDDigestive Diseases and Sciences, 2005